Introduction
The global health landscape is grappling with renewed challenges as the World Health Organization (WHO) reports a troubling increase in tuberculosis (TB) cases. Concurrently, a study reveals long-term cardiovascular risks associated with Long COVID, and the U.S. Food and Drug Administration (FDA) has approved a new weight management drug amid an ongoing obesity epidemic.
